Science Explorer Back to mapMap

Most cited papers from Institut National du Cancer

What are the most cited papers from Institut National du Cancer?

The most cited paper from Institut National du Cancer is "The repertoire of mutational signatures in human cancer" (Ludmil B. Alexandrov et al., 2020), with 3,854 citations. Next come "Pan-cancer analysis of whole genomes" (3,360) and "International network of cancer genome projects" (2,439).

Showing 50 of 60 papers. Every paper with more than 103 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 The repertoire of mutational signatures in human cancer Ludmil B. Alexandrov et al. · Nature Open access1,384 authors 5 Feb 2020 3,854
2 Pan-cancer analysis of whole genomes Lauri A. Aaltonen et al. · Nature Open access1,324 authors 5 Feb 2020 3,360
3 International network of cancer genome projects Jennifer L. Jennings et al. · Nature Open access256 authors 13 Apr 2010 2,439
4 Landscape of somatic mutations in 560 breast cancer whole-genome sequences Serena Nik‐Zainal et al. · Nature Open access 29 Apr 2016 2,395
5 Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma Cécile Guichard, Giuliana Amaddeo, Sandrine Imbeaud et al. · Nature Genetics Open access 6 May 2012 1,489
6 The evolutionary history of 2,658 cancers Moritz Gerstung et al. · Nature Open access1,441 authors 5 Feb 2020 1,149
7 Patterns of somatic structural variation in human cancer genomes Yilong Li et al. · Nature Open access1,411 authors 5 Feb 2020 1,005
8 Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer gastric · JAMA 4 May 2010 806
9 Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing Isidro Cortés-Ciriano et al. · Nature Genetics Open access1,407 authors 5 Feb 2020 793
10 SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma Éric Letouzé, Cosimo Martinelli, Céline Loriot et al. · Cancer Cell Open access 23 May 2013 790
11 Analyses of non-coding somatic drivers in 2,658 cancer whole genomes Esther Rheinbay et al. · Nature Open access1,621 authors 5 Feb 2020 674
12 SDHA is a tumor suppressor gene causing paraganglioma Nelly Burnichon, Jean-Jacques Brière, Rossella Libé et al. · Human Molecular Genetics Open access 18 May 2010 654
13 The Impact of Nutrition and Environmental Epigenetics on Human Health and Disease Céline Tiffon · International Journal of Molecular Sciences Open access Nov 2018 504
14 Genomic basis for RNA alterations in cancer PCAWG Transcriptome Core Group et al. · Nature Open access1,461 authors 5 Feb 2020 425
15 The landscape of viral associations in human cancers Marc Zapatka et al. · Nature Genetics Open access1,355 authors 5 Feb 2020 412
16 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet Oncology 11 Jun 2013 343
17 Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma Nelly Burnichon, Laure Vescovo, Laurence C. Amar et al. · Human Molecular Genetics Open access 22 Jul 2011 311
18 Genomic Profiling of Hepatocellular Adenomas Reveals Recurrent FRK-Activating Mutations and the Mechanisms of Malignant Transformation Camilla Pilati et al. · Cancer Cell Open access Apr 2014 273
19 Mapping low intake of micronutrients across Europe Gert Mensink, Richard A. Fletcher, Mirjana A Gurinović et al. · British Journal Of Nutrition Open access 14 Jan 2013 266
20 Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study Rossella Libé et al. · Annals of Oncology Open access 21 Sep 2015 262
21 Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer Nathalie Druesne‐Pecollo, B. Téhard, Yann Mallet et al. · The Lancet Oncology 30 Jan 2009 256
22 A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns Wei Jiao et al. · Nature Communications Open access1,385 authors 5 Feb 2020 246
23 Integrative pathway enrichment analysis of multivariate omics data Marta Paczkowska et al. · Nature Communications Open access1,460 authors 5 Feb 2020 243
24 The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas Judith Favier, Jean-Jacques Brière, Nelly Burnichon et al. · PLoS ONE Open access 18 Sep 2009 233
25 Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses Menglin Wang et al. · Nature Biotechnology Open access 25 Sep 2023 209
26 SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma Julien Hadoux, Judith Favier, Jean‐Yves Scoazec et al. · International Journal of Cancer Open access 19 Apr 2014 208
27 Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial Denis Moro‐Sibilot et al. · Annals of Oncology Open access 27 Sep 2019 199
28 Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis Joana Carlevaro-Fita et al. · Communications Biology Open access1,462 authors 5 Feb 2020 195
29 Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations Julien Mazières et al. · Annals of Oncology Open access 6 Jan 2020 193
30 Adherence to the French Programme National Nutrition Santé Guideline Score Is Associated with Better Nutrient Intake and Nutritional Status Carla Estaquio, Emmanuelle Kesse‐Guyot, Valérie Deschamps et al. · Journal of the American Dietetic Association 22 May 2009 193
31 Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells Young Seok Ju et al. · Genome Research Open access 11 May 2015 178
32 Underrepresentation of Elderly People in Randomised Controlled Trials. The Example of Trials of 4 Widely Prescribed Drugs Cécile Konrat, Isabelle Boutron, Ludovic Trinquart et al. · PLoS ONE Open access 30 Mar 2012 170
33 A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers Anthony Ferrari et al. · Nature Communications Open access 13 Jul 2016 162
34 Mitotane Therapy in Adrenocortical Cancer Induces CYP3A4 and Inhibits 5α-Reductase, Explaining the Need for Personalized Glucocorticoid and Androgen Replacement Vasileios Chortis et al. · The Journal of Clinical Endocrinology & Metabolism Open access 16 Nov 2012 156
35 The research burden of randomized controlled trial participation: a systematic thematic synthesis of qualitative evidence Nivantha Naidoo, Van Thu Nguyen, Philippe Ravaud et al. · BMC Medicine Open access 19 Jan 2020 153
36 Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma Nelly Burnichon, Alexandre Buffet, Béatrice Parfait et al. · Human Molecular Genetics 6 Sep 2012 148
37 Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma Betty Gardie et al. · Journal of Medical Genetics Open access 12 Mar 2011 145
38 Tuning PID Controller Using Multiobjective Ant Colony Optimization Chiha Ibtissem, Noureddine Liouane, Pierre Borne · Applied Computational Intelligence and Soft Computing Open access 2012 144
39 Genomic footprints of activated telomere maintenance mechanisms in cancer Lina Sieverling et al. · Nature Communications Open access1,414 authors 5 Feb 2020 143
40 Divergent mutational processes distinguish hypoxic and normoxic tumours Vinayak Bhandari et al. · Nature Communications Open access1,328 authors 5 Feb 2020 143
41 Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative Jan Bogaerts et al. · European Journal of Cancer Open access 24 Dec 2014 137
42 2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group Philippe M Debourdeau, D. Kassab Chahmi, Grégoire Le Gal et al. · Annals of Oncology Open access 13 Jun 2009 135
43 Measuring exposure to the polyphenol metabolome in observational epidemiologic studies: current tools and applications and their limits Raúl Zamora‐Ros, Marina S. Touillaud, Joseph A. Rothwell et al. · American Journal of Clinical Nutrition Open access May 2014 134
44 Epithelial to Mesenchymal Transition Is Activated in Metastatic Pheochromocytomas and Paragangliomas Caused by SDHB Gene Mutations Céline Loriot, Nelly Burnichon, Noémie Gadessaud et al. · The Journal of Clinical Endocrinology & Metabolism 5 Apr 2012 132
45 Identification of a CpG Island Methylator Phenotype in Adrenocortical Carcinomas Olivia Barreau, Guillaume Assié, Hortense Wilmot-Roussel et al. · The Journal of Clinical Endocrinology & Metabolism 24 Oct 2012 131
46 Sex differences in oncogenic mutational processes Constance H. Li et al. · Nature Communications Open access1,376 authors 28 Aug 2020 130
47 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial Xavier B. Pivot et al. · The Lancet Open access346 authors Jun 2019 129
48 Head and Neck Paragangliomas in Von Hippel-Lindau Disease and Multiple Endocrine Neoplasia Type 2 Carsten C. Boedeker et al. · The Journal of Clinical Endocrinology & Metabolism Open access 31 Mar 2009 129
49 Isocitrate Dehydrogenase Mutations Are Rare in Pheochromocytomas and Paragangliomas José Gaal, Nelly Burnichon, Esther Korpershoek et al. · The Journal of Clinical Endocrinology & Metabolism 14 Nov 2009 127
50 Alcoholic beverages, obesity, physical activity and other nutritional factors, and cancer risk: A review of the evidence Paule Latino‐Martel, Vanessa Cottet, Nathalie Druesne‐Pecollo et al. · Critical Reviews in Oncology/Hematology Open access 15 Jan 2016 126

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.